Compassion-focused therapy (CFT) for the reduction of the self-stigma of mental disorders: the COMpassion for Psychiatric disorders, Autism and Self-Stigma (COMPASS) study protocol for a randomized controlled study.

Date publication

juin 2023

Journal

Trials

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ROHMER Odile

Tous les auteurs :
Riebel M, Rohmer O, Charles E, Lefebvre F, Weibel S, Weiner L

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37309006

Résumé

People with mental disorders face frequent stigmatizing attitudes and behaviors from others. Importantly, they can internalize such negative attitudes and thus self-stigmatize. Self-stigma is involved in diminished coping skills leading to social avoidance and difficulties in adhering to care. Reducing self-stigma and its emotional corollary, shame, is thus crucial to attenuate the negative outcomes associated with mental illness. Compassion-focused therapy (CFT) is a third-wave cognitive behavioral therapy that targets shame reduction and hostile self-to-self relationship and allows for symptom improvement while increasing self-compassion. Although shame is a prominent part of the concept of self-stigma, the efficacy of CFT has never been evaluated in individuals with high levels of self-stigma. The purpose of this study is to evaluate the efficacy and acceptability of a group-based CFT program on self-stigma, compared to a psychoeducation program for self-stigma (Ending Self-Stigma) and to treatment as usual (TAU). We hypothesize that diminished shame and emotional dysregulation and increased self-compassion will mediate the relationship between self-stigma improvements post-therapy in the experimental group.

Mots clés

Autism spectrum disorder, Bipolar disorder, Borderline personality disorder, Cognitive-behavioral therapy, Compassion-focused therapy (CFT), Depression, Ending Self-Stigma, Randomized controlled trial (RCT), Schizophrenia, Self-stigma, Severe mental illness (SMI), Shame

Référence

Trials. 2023 06 12;24(1):393